Skip to content

Phase 3 Study of Tramadol Hydrochloride/Acetaminophen SR Tab. & Tramadol Hydrochloride/Acetaminophen Tab. in Acute Toothache Patients After Teeth Extraction Surgery

A Randomized, Double-blind, Active-controlled, Parallel, Multicenter Phase 3 Study of Tramadol Hydrochloride/Acetaminophen SR Tab. & Tramadol Hydrochloride/Acetaminophen Tab. in Acute Toothache Patients After Teeth Extraction Surgery

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01920386
Enrollment
240
Registered
2013-08-12
Start date
2013-06-30
Completion date
Unknown
Last updated
2016-10-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Toothache Patients Above Moderate Pain After Teeth Extraction Surgery

Keywords

Acute Toothache, Wontran, Wontran SR Tab., Tramadol Hydrochloride/Acetaminophen

Brief summary

A randomized, double-blind, active-controlled, parallel, multicenter Phase 3 study of Tramadol hydrochloride/Acetaminophen SR Tab. & Tramadol hydrochloride/Acetaminophen Tab. in Acute Toothache Patients above Moderate Pain after Teeth Extraction Surgery.

Interventions

Sponsors

Daewon Pharmaceutical Co., Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Adult males/Females aged over 20 years 2. Patients with over 2 impacted wisdom teeth in the upper and lower jaws 3. Pain VAS Value over 50 mm evaluated as 100mm VAS 4. Subjects who voluntarily or legal guardian agreed with written consent

Exclusion criteria

1. Patients with severe heart disease, uncontrol hypertension, diabetes 2. Patients who had taken a long period NSAID (eg. celecoxib, rofecoxib naproxen etc) within 3 days from the screening point 3. Patients who had taken short-time anesthetic drugs and analgesics within 12 hours from the screening point (except short-time anesthetics before or during surgery) 4. Patients with aspirin asthma(asthma seizure caused by NSAIDs) or medical history 5. Patients with severe respiratory depression

Design outcomes

Primary

MeasureTime frame
SPID ; Sum of the pain intensity differences0, 0.5, 1, 2, 3, 4, 5, 6, 8, 12 hour

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026